Related Experiment Video

Updated: Jun 28, 2026

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants
14:56

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants

Published on: February 8, 2012

New evaluation of the Toxoplasma ELITe MGB assay on the ELITe Ingenius™ platform (ELITechGroup)

Marie-Pierre Brenier-Pinchart1,2,3, Cécile Garnaud4,5, Gaelle Dewaele4

  • 1Service de Parasitologie-Mycologie, CHU Grenoble Alpes, Grenoble, France. mpbrenierpinchart@chu-grenoble.fr.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|September 18, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
09:49

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

Related Experiment Videos

Last Updated: Jun 28, 2026

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants
14:56

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants

Published on: February 8, 2012

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
09:49

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

Related Concept Videos

Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

Articles linked to this work by shared authors, journal, and citation graph.

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026

Seasonal variations in mold identification in medical microbiology laboratories using MSI-2 application, France (2020-2024).

Medical mycology·2026

Immunological fitness of echinocandin-resistant Nakaseomyces glabratus (former Candida glabrata): The impact on the management of candidemia.

Virulence·2026

Assessing laboratory capacity for diagnosis of fungal infections in France: A multicentre survey within the SINFONI network.

Medical mycology·2026

Diagnosis and treatment of congenital toxoplasmosis: an updated overview.

Expert review of anti-infective therapy·2026

Clinical characteristics and treatments of imported loiasis patients with microfilaraemia diagnosed in France, 2000-2022.

Travel medicine and infectious disease·2026

Suspected acute bacterial meningitis in adult emergency department: use of imaging before lumbar puncture and association with time to antibiotic initiation - a multicentre retrospective study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Impact on blood cultures pre-analytical quality and positivity rate of a key performance indicators digital monitoring approach: a pre-post intervention study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Validation of an innovative tissue-cage/beads rabbit model for ex vivo determination of minimum levels of Staphylococcus aureus biofilm eradication.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Effect of an antibiotic stewardship program on antimicrobial use and resistance in a high prescribing, high resistance setting: A single-center, interrupted time series analysis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Development of a rapid diagnostic test for the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus: Cefinase disk direct (CDD) test.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

A Rapid Molecular Detection Method for Streptococcus agalactiae Based on Bacteriophage Lysin Lysis and Real-Time PCR.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Validation and performance of a rapid HIV-1 viral load assay.

Microbiology spectrum·2026

Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026

Microneedle biosensors: from molecular recognition to intelligent diagnostics.

Chemical communications (Cambridge, England)·2026

HOMEBRED: A unified CRISPR platform for field-ready shadowing of infectious agents and oncogenic mutations.

iScience·2026

Identification of occult hepatitis B infection despite high anti-HBs in a hemodialysis patient during pretransplant evaluation.

IDCases·2026

Recent advances in biomarkers for cardiac fibrosis.

Frontiers in cardiovascular medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us